Relationship between Il28b Gene Polymorphisms and the Risk of Hepatocellular Carcinoma Development within Vietnamese Hepatitis B Virus Carriers
Open Access
- 22 June 2017
- journal article
- Published by Peertechz Publications Private Limited in Journal of Clinical Microbiology and Biochemical Technology
- Vol. 3 (2), 035-039
- https://doi.org/10.17352/jcmbt.000024
Abstract
IL28B’s SNPs are considered the most important host factors predicting the success of Peg-INF alpha/ribavirin based regimens against Hepatitis C virus (HCV) infection.Keywords
This publication has 18 references indexed in Scilit:
- Association of two polymorphisms of the IL28B gene with viral factors and treatment response in 1,518 patients infected with hepatitis C virusThe Esophagus, 2012
- IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: Role in the course of chronic viral hepatitis and the development of HCCJournal of Hepatology, 2011
- HCV-related hepatocellular carcinoma: From chronic inflammation to cancerClinical Immunology, 2010
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis CNature Genetics, 2009
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapyNature Genetics, 2009
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearanceNature, 2009
- An enormous hepatitis B virus‐related liver disease burden projected in Vietnam by 2025Liver International, 2008
- Hepatitis B Virus Infection — Natural History and Clinical ConsequencesThe New England Journal of Medicine, 2004
- Course and outcome of hepatitis CJournal of Hepatology, 2002